• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[慢性疼痛模型中的表观遗传机制——新型治疗靶点?]

[EPIGENETIC MECHANISMS IN MODELS OF CHRONIC PAIN - A TARGET FOR NOVEL THERAPY?].

作者信息

Anis Saar, Mosek Amnon

机构信息

Neurology Department, Sourasky Medical Center, Tel Aviv, Israel.

Sackler Faculty of Medicine, Tel Aviv University.

出版信息

Harefuah. 2018 Jun;157(6):370-373.

PMID:29964377
Abstract

Evidence of epigenetics' role in pain response is accumulating in recent years. Tightly regulated epigenetic alterations on DNA and histones in the sensory circuit shape the physiological response to injury. Altering those epigenetic processes hinders therapeutic potential in pain. This review provides an overview of epigenomic modification in the development of chronic pain, and summarizes the therapeutic potential to alter epigenetic processes.

摘要

近年来,表观遗传学在疼痛反应中作用的证据不断积累。感觉回路中DNA和组蛋白上受到严格调控的表观遗传改变塑造了对损伤的生理反应。改变这些表观遗传过程会阻碍疼痛治疗的潜力。本综述概述了慢性疼痛发展过程中的表观基因组修饰,并总结了改变表观遗传过程的治疗潜力。

相似文献

1
[EPIGENETIC MECHANISMS IN MODELS OF CHRONIC PAIN - A TARGET FOR NOVEL THERAPY?].[慢性疼痛模型中的表观遗传机制——新型治疗靶点?]
Harefuah. 2018 Jun;157(6):370-373.
2
Epigenetic regulation of chronic pain.慢性疼痛的表观遗传调控。
Epigenomics. 2015;7(2):235-45. doi: 10.2217/epi.14.75.
3
Could targeting epigenetic processes relieve chronic pain states?靶向表观遗传过程能否缓解慢性疼痛状态?
Curr Opin Support Palliat Care. 2015 Jun;9(2):138-46. doi: 10.1097/SPC.0000000000000127.
4
[Epigenetics' implication in autism spectrum disorders: A review].[表观遗传学在自闭症谱系障碍中的影响:综述]
Encephale. 2017 Aug;43(4):374-381. doi: 10.1016/j.encep.2016.07.007. Epub 2016 Sep 28.
5
Epigenetics of chronic pain after thoracic surgery.胸外科手术后慢性疼痛的表观遗传学。
Curr Opin Anaesthesiol. 2014 Feb;27(1):1-5. doi: 10.1097/ACO.0000000000000030.
6
Epigenetic mechanisms of chronic pain.慢性疼痛的表观遗传机制
Trends Neurosci. 2015 Apr;38(4):237-46. doi: 10.1016/j.tins.2015.02.001. Epub 2015 Mar 9.
7
Targeting Epigenetic Mechanisms for Chronic Pain: A Valid Approach for the Development of Novel Therapeutics.针对慢性疼痛的表观遗传机制:开发新型疗法的有效途径。
J Pharmacol Exp Ther. 2016 Apr;357(1):84-93. doi: 10.1124/jpet.115.231670. Epub 2016 Jan 19.
8
Epigenetics and the transition from acute to chronic pain.表观遗传学与急性痛向慢性痛的转变。
Pain Med. 2012 Nov;13(11):1474-90. doi: 10.1111/j.1526-4637.2012.01488.x. Epub 2012 Sep 14.
9
Epigenetic regulation of persistent pain.持续性疼痛的表观遗传调控
Transl Res. 2015 Jan;165(1):177-99. doi: 10.1016/j.trsl.2014.05.012. Epub 2014 May 29.
10
Epigenetic alternations and cancer chemotherapy response.表观遗传改变与癌症化疗反应。
Cancer Chemother Pharmacol. 2016 Apr;77(4):673-84. doi: 10.1007/s00280-015-2951-0. Epub 2015 Dec 26.

引用本文的文献

1
Effects of unpredictable chronic mild stress of female rats before pregnancy on morphine-induced antinociceptive tolerance in offspring.雌性大鼠孕期前不可预测的慢性轻度应激对后代吗啡诱导的抗伤害感受性耐受的影响。
Korean J Pain. 2025 Jul 1;38(3):258-266. doi: 10.3344/kjp.24403. Epub 2025 May 19.
2
POU2F1/DNMT3a Pathway Participates in Neuropathic Pain by Hypermethylation-Mediated LRFN4 Downregulation Following Oxaliplatin Treatment.POU2F1/DNMT3a 通路通过奥沙利铂治疗后的 LRFN4 下调介导的超甲基化参与神经病理性疼痛。
Neurochem Res. 2023 Dec;48(12):3652-3664. doi: 10.1007/s11064-023-04011-w. Epub 2023 Aug 18.
3
ZEB1 Induces Ddr1 Promoter Hypermethylation and Contributes to the Chronic Pain in Spinal Cord in Rats Following Oxaliplatin Treatment.
ZEB1诱导Ddr1启动子高甲基化并导致奥沙利铂治疗后大鼠脊髓慢性疼痛。
Neurochem Res. 2021 Aug;46(8):2181-2191. doi: 10.1007/s11064-021-03355-5. Epub 2021 May 25.
4
Upregulation of TRPC6 Mediated by PAX6 Hypomethylation Is Involved in the Mechanical Allodynia Induced by Chemotherapeutics in Dorsal Root Ganglion.PAX6 低甲基化调控 TRPC6 的表达参与化疗药物诱导的背根神经节机械性痛觉过敏。
Int J Neuropsychopharmacol. 2020 Apr 23;23(4):257-267. doi: 10.1093/ijnp/pyaa014.